Prescription drug · ANDA
dasatinib NDC 70771-1905
Dasatinib 100 mg/1 · Tablet · Oral · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1905-3 | 70771190503 | 30 TABLET in 1 BOTTLE (70771-1905-3)Marketed from Mar 3, 2025 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- dasatinib
- Generic name (nonproprietary)
- dasatinib
- Active ingredients
- Dasatinib — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 218719
- Marketing start
- Listing expires
- Other FDA classes
- Cytochrome P450 3A4 Inhibitors (Mechanism)Protein Kinase Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1905_571889d7-845d-4fed-8d7d-6470d4d36fa1SPL ID 571889d7-845d-4fed-8d7d-6470d4d36fa1SPL set ID 4eed6b7b-a09d-4d2e-a345-968dd68323bcRxCUI 643105, 643107, 643109, 799047, 1045402, 1045406UNII RBZ1571X5HUPC 0370710174439, 0370710174163, 0370710174262, 0370710174637, 0370710174361, 0370710174538
- Pharmacologic class
- Kinase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N470771190503followed by a unit qualifier and the quantityPackage 70771-1905-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 218719
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| dasatinib | Dasatinib 70 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1903 |
| dasatinib | Dasatinib 20 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1901 |
| dasatinib | Dasatinib 50 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1902 |
| dasatinib | Dasatinib 70 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1743 |
| dasatinib | Dasatinib 80 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1904 |
| dasatinib | Dasatinib 20 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1741 |
| dasatinib | Dasatinib 140 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1906 |
| dasatinib | Dasatinib 50 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1742 |
| dasatinib | Dasatinib 140 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1746 |
| dasatinib | Dasatinib 80 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1744 |
| dasatinib | Dasatinib 100 mg/1 | TabletOral | Zydus Pharmaceuticals USA Inc. | 70710-1745 |